MRNA is S&P 500's top performing stock, here are the best Quant pharma companies
Source: SeekingAlpha
2026-01-21 14:36:34 ET
More on pharmaceuticals
- XPH: Healthcare Dashboard For January
- Why PPH Keeps Working When Single Themes Break
- Healthcare Dashboard For December And Focus On PJP
- Market Voices: Trump on Venezuela, CPI data issues, drug pricing deals
- Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock
Read the full article on Seeking Alpha
For further details see:
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies
Innoviva Inc.
NASDAQ: INVA
INVA Trading
2.25% G/L:
$22.25 Last:
212,105 Volume:
$21.75 Open:
INVA Latest News
February 25, 2026 04:05:00 pm
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
INVA Stock Data
$1,619,124,038
73,086,758
0.35%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
Burlingame
